- A quality expert and lead oncology hospitalist from the Dana-Farber Cancer Institute in Boston – the principal teaching affiliate for Harvard Medical School and one of the nation’s highest-ranked cancer hospitals – is the new Chief Medical Officer of University Hospitals Seidman Cancer Center.
cker, MD, brings 15 years of experience at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. As an assistant professor at Harvard Medical School, Dr. Glotzbecker was honored with awards from the Dana-Farber/Harvard Cancer Center for excellence in teaching and quality achievement. She had been the principal investigator on multiple funded projects, most recently to compare outcomes for hematopoietic cell transplant patients and another to improve communication toward a more efficient discharge process.
“The UH Seidman Cancer Center family is so fortunate to have attracted a physician leader of Dr. Glotzbecker’s stature. Her expertise in patient experience, quality and clinical care delivery will help us achieve our stated goal of being the US leader in value based cancer care,” said Theodoros N. Teknos, MD, President and Scientific Director of UH Seidman Cancer Center.
Dr. Glotzbecker received her medical degree and a bachelor’s degree in bioengineering from the University of Pennsylvania in Philadelphia. She completed her residency in internal medicine and her clinical/research fellowship in hematology and medical oncology from Beth Israel Deaconess Medical Center in Boston.
As Chief Medical Officer, Dr. Glotzbecker will oversee quality and the patient experience for all disease teams and tumor conferences, providing focused leadership for achieving all key certifications. She will be the senior physician liaison for cancer practitioners throughout the system. Dr. Glotzbecker will work closely with Nursing, Medical Staff and Quality. As a physician of University Hospitals Medical Group and the Department of Medicine Division of Hematology and Oncology, Dr. Glotzbecker also will provide inpatient clinical care or other care, such as consults, tumor boards and call coverage.